2020 Bulkers Raises USD 3 Mln

2020-bulkers

2020 Bulkers has raised net proceeds of USD 3 million through a private placement.

On February 5, the company said that it conducted a private placement of 300,000 new shares, each at a subscription price of USD 10.0 per share. Subsequent to the closing of the private placement, 2020 Bulkers Ltd has 14,370,906 shares outstanding.

The proceeds from the private placement would be used towards yard instalments for eight Newcastlemax vessels currently under construction at New Times Shipyard in China, as well as for general corporate purposes, the company added.

LEAVE A COMMENT

Comments (17)

hydroxychloroquine online canada

2020 Bulkers Raises USD 3 Mln | Shipping Herald

hydroxychloroquine and cardiac issues

2020 Bulkers Raises USD 3 Mln | Shipping Herald

clomid 50mg uk

2020 Bulkers Raises USD 3 Mln | Shipping Herald

buy generic vidalista

2020 Bulkers Raises USD 3 Mln | Shipping Herald

ivermectin wormer to treat cancer

2020 Bulkers Raises USD 3 Mln | Shipping Herald

tips for using ivermectin

2020 Bulkers Raises USD 3 Mln | Shipping Herald

trump ownership hydroxychloroquine

2020 Bulkers Raises USD 3 Mln | Shipping Herald

coupon for vidalista 20

2020 Bulkers Raises USD 3 Mln | Shipping Herald

kroger prescription refill online

2020 Bulkers Raises USD 3 Mln | Shipping Herald

is too much albuterol bad for you

2020 Bulkers Raises USD 3 Mln | Shipping Herald

price of dapoxetine daily

2020 Bulkers Raises USD 3 Mln | Shipping Herald

doxycycline monohydrate dosage for dogs

2020 Bulkers Raises USD 3 Mln | Shipping Herald

cenforce patient information sheet

2020 Bulkers Raises USD 3 Mln | Shipping Herald

chloroquine malaria drug side effects

2020 Bulkers Raises USD 3 Mln | Shipping Herald

trump and hydroxychloroquine connection

2020 Bulkers Raises USD 3 Mln | Shipping Herald

hydroxychloroquine sulfate tablet 200 mg

2020 Bulkers Raises USD 3 Mln | Shipping Herald

generic names for cialis and viagra

2020 Bulkers Raises USD 3 Mln | Shipping Herald

×

Comments are closed.